Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Purine analogs, antimetabolites antineoplastic

Known as: Purine analogues 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

purine analog

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant
Objective: To review the literature for the treatment of classical and variant hairy cell leukemia (HCL, HCLv), evaluating… Expand
2019
2019
[Hairy cell leukemia].
Hairy cell leukemia (HCL) is a well-defined entity. Proliferation with hair cells, morphological aspects of hairy cells are easy… Expand
Review
2018
Review
2018
Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia?
Hairy-cell leukaemia (HCL) is a B-cell lymphoproliferative disorder with a distinct morphological, molecular and immunophenotypic… Expand
Review
2017
Review
2017
How I manage patients with hairy cell leukaemia
Patients with hairy cell leukaemia (HCL) have highly favourable outcomes after purine analogue therapy. However, most patients… Expand
Review
2016
Review
2016
Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.
BACKGROUND AND AIMS Tacrolimus is recommended for the treatment of steroid-refractory ulcerative colitis (UC). Concomitantly… Expand
2014
2014
Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administration.
BACKGROUND The combination of purine analogues (PA) and rituximab (chemoimmunotherapy) is considered the treatment of choice for… Expand
Review
2009
Review
2009
Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator…
Abstract 3828 Poster Board III-764 Background tMDS/tAML are recognised late complications of chemotherapy and increased risk… Expand
2006
2006
[Hairy cell leukemia: prognosis and treatment].
AIMS To analyze clinical and laboratory features at presentation in correlation to treatment response and overall survival… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE